22157.jpg
Global Ventricular Assist Devices (VADs) Market, 2028 - Featuring Profiles of ABIOMED, Medtronic, Abbott, Berlin Heart, Cardiac Assist, and More
December 30, 2021 08:28 ET | Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Global Ventricular Assist Device Market Size, Share & Trends Analysis Report by Product, by Type Of Flow (Pulsatile Flow, Continuous Flow), by...
22157.jpg
Global Heart Pump Device Market (2021 to 2026) - Increasing Number of Product Approvals Presents Opportunities
June 11, 2021 04:58 ET | Research and Markets
Dublin, June 11, 2021 (GLOBE NEWSWIRE) -- The "Global Heart Pump Device Market by Product (Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD), Intra-aortic Balloon Pumps, TAH), Type...
22157.jpg
Worldwide Ventricular Assist Device Industry to 2025 - North America Dominates the Market
December 21, 2020 07:38 ET | Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Ventricular Assist Device Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The...
Wayside Logo.jpg
Wayside Technology Group, Inc. Announces Promotion of Dale Foster to the Role of President of Lifeboat
July 03, 2019 07:00 ET | Wayside Technology Group, Inc.
EATONTOWN, N.J., July 03, 2019 (GLOBE NEWSWIRE) -- Wayside Technology Group, Inc. (NASDAQ: WSTG) (the "Company") today announced that Dale Foster has been promoted to the role of President of...
Duo Logo - Green (1).png
Ignition Technology and Duo Security Pair to Accelerate Zero-Trust Security Adoption in Partner Community
November 01, 2018 05:00 ET | Duo Security
Leading enterprise Unified Access Security provider selects Ignition as first and sole UK VAD partner LONDON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- The latest addition to Ignition Technology’s...
MEDAMACS 1-YEAR STUDY RESULTS ON ADVANCED HEART FAILURE INDICATE CLINICIANS SHOULD EXPAND VAD THERAPY TO THOSE PREVIOUSLY THOUGHT AS ‘TOO HEALTHY’ San Diego, April 08, 2017 (GLOBE NEWSWIRE) -- Today researchers presented findings of the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) study, a multi-center, U.S.-based study,...
National Institutes of Health and Mesoblast Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure
August 06, 2014 20:57 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today announced the signing of an agreement with the United...
Mesoblast's Cell Therapy Strengthens Native Heart Function In Patients With End-Stage Heart Failure on Assisted Circulatory Support
November 18, 2013 18:14 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Patients with end-stage or New York Heart Association (NYHA) class IV heart failure who receive a surgically implanted left...